Skip Navigation


Rheumatology Advance Access originally published online on February 21, 2007
Rheumatology 2007 46(6):920-926; doi:10.1093/rheumatology/kem014
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/6/920    most recent
kem014v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Xu, H.
Right arrow Articles by Sun, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, H.
Right arrow Articles by Sun, L.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Anti-malarial agent artesunate inhibits TNF-{alpha}-induced production of proinflammatory cytokines via inhibition of NF-{kappa}B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes

H. Xu, Y. He, X. Yang, L. Liang, Z. Zhan, Y. Ye, X. Yang1, F. Lian and L. Sun2

Department of Rheumatology and 1Department of Nephrology, The First Affiliated Hospital, SUN Yat-sen University, Guangzhou, Guangdong, PR China and 2Department of Pathology, School of Medicine, Northwestern University, Chicago, IL, USA

Correspondence to: H. Xu, MD, PhD, Department of Rheumatology, The First Affiliated Hospital, SUN Yat-sen University, NO 58 Zhongshan Road 2, Guangzhou, Guangdong 510080, PR China. E-mail: xuhanshi{at}hotmail.com; xuhanshi{at}mail.sysu.edu.cn


   Abstract

Objectives. Recent studies indicate that the anti-malarial agent artemisinin and its derivatives may exert an anti-inflammatory effect. In this study, we explored the effect of artesunate, an artemisinin derivative, on tumour necrosis factor (TNF)-{alpha}-induced production of interleukins, IL-1ß, IL-6 and IL-8, in human rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS), and further investigated the signal mechanism by which this compound modulates those cytokines' production.

Methods. RA FLS obtained from patients with active RA were stimulated with TNF-{alpha} and incubated with artesunate, and IL-1ß, IL-6 and IL-8 production was measured by ELISA. DNA-binding activity and nuclear translocation of nuclear factor kappa B (NF-{kappa}B) were measured by a sensitive multi-well colourimetric assay and confocal fluorescence microscopy, respectively. Signal transduction proteins expression was measured by western blot.

Results. Artesunate decreased the secretion of IL-1ß, IL-6 and IL-8 from TNF-{alpha}-stimulated RA FLS in a dose-dependent manner. Artesunate also prevented TNF-{alpha}-induced nuclear NF-{kappa}B translocation, DNA-binding activity and gene transcriptional activity, as well as phosphorylation and degradation of I{kappa}B{alpha}, but phosphorylation of p38 mitogen-activated protein kinase, extracelluar signal-regulated kinase and c-Jun N-terminal kinase were unaffected. The production of IL-1ß, IL-6 and IL-8 induced by TNF-{alpha} was decreased by pyrrolidine dithiocarbamate (PDTC), a chemical inhibitor of NF-{kappa}B. These observations suggest that artesunate inhibits production of IL-1ß, IL-6 and IL-8 through inhibition of NF-{kappa}B signalling pathway. We also showed that artesunate prevented Akt phosphorylation. TNF-{alpha}-induced production of IL-1ß, IL-6 and IL-8 was hampered by treatment with the phosphatidylinositol 3 (PI3) kinase inhibitor LY294002, suggesting that inhibition of Akt activation might inhibit IL-1ß, IL-6 and IL-8 production induced by TNF-{alpha}.

Conclusions. Our results indicate that artesunate exerts an anti-inflammatory effect in RA FLS and provide the evidence that artesunate may have therapeutic potential for RA.

KEY WORDS: Artesunate, Cytokines, Rheumatoid arthritis, Signal transduction, Fibroblast-like synoviocytes

Submitted 11 September 2006; revised version accepted 5 January 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.